{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:28:37Z","timestamp":1791088117305,"version":"4.1.0"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2007,3,3]],"date-time":"2007-03-03T00:00:00Z","timestamp":1172880000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,3,3]],"date-time":"2007-03-03T00:00:00Z","timestamp":1172880000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Imaging Biol"],"published-print":{"date-parts":[[2007,7]]},"DOI":"10.1007\/s11307-007-0085-4","type":"journal-article","created":{"date-parts":[[2007,3,2]],"date-time":"2007-03-02T14:03:48Z","timestamp":1172844228000},"page":"223-233","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Functional Imaging of Cerebral Blood Flow and Glucose Metabolism in Parkinson\u2019s Disease and Huntington\u2019s Disease"],"prefix":"10.1007","volume":"9","author":[{"given":"Yilong","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Eidelberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,3,3]]},"reference":[{"key":"85_CR1","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1006\/nimg.1997.0294","volume":"6","author":"KJ Worsley","year":"1997","unstructured":"Worsley KJ, Poline JB, Friston KJ, Evans AC (1997) Characterizing the response of PET and fMRI data using multivariate linear models. NeuroImage 6:305\u2013319","journal-title":"NeuroImage"},{"key":"85_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1006\/nimg.1996.0074","volume":"4","author":"KJ Friston","year":"1996","unstructured":"Friston KJ, Holmes A, Poline JB, Price CJ, Frith CD (1996) Detecting activations in PET and fMRI: levels of inference and power. NeuroImage 4:223\u2013235","journal-title":"NeuroImage"},{"key":"85_CR3","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/S1053-8119(03)00333-1","volume":"20","author":"FH Lin","year":"2003","unstructured":"Lin FH, McIntosh AR, Agnew JA, Eden GF, Zeffiro TA, Belliveau JW (2003) Multivariate analysis of neuronal interactions in the generalized partial least squares framework: simulations and empirical studies. NeuroImage 20:625\u2013642","journal-title":"NeuroImage"},{"key":"85_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/hbm.460020108","volume":"2","author":"G Alexander","year":"1994","unstructured":"Alexander G, Moeller J (1994) Application of the scaled subprofile model to functional imaging in neuropsychiatric disorders: a principal component approach to modeling brain function in disease. Hum Brain Mapp 2:1\u201316","journal-title":"Hum Brain Mapp"},{"key":"85_CR5","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/jcbfm.1994.99","volume":"14","author":"D Eidelberg","year":"1994","unstructured":"Eidelberg D, Moeller JR, Dhawan V, Spetsieris P, Takikawa S, Ishikawa T, et al. (1994) The metabolic topography of parkinsonism. J Cereb Blood Flow Metab 14:783\u2013801","journal-title":"J Cereb Blood Flow Metab"},{"key":"85_CR6","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1002\/hbm.10069","volume":"18","author":"G Zuendorf","year":"2003","unstructured":"Zuendorf G, Kerrouche N, Herholz K, Baron JC (2003) Efficient principal component analysis for multivariate 3D voxel-based mapping of brain functional imaging data sets as applied to FDG-PET and normal aging. Hum Brain Mapp 18:13\u201321","journal-title":"Hum Brain Mapp"},{"key":"85_CR7","doi-asserted-by":"crossref","unstructured":"Ma Y, Tang C, Spetsieris PG, Dhawan V, Eidelberg D (2006) Abnormal metabolic network activity in Parkinson\u2019s disease: test\u2013retest reproducibility. J Cereb Blood Flow Metab (in press). DOI 10.1038\/sj.jcbfm.9600358","DOI":"10.1038\/sj.jcbfm.9600358"},{"key":"85_CR8","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1212\/WNL.57.11.2083","volume":"57","author":"A Feigin","year":"2001","unstructured":"Feigin A, Fukuda M, Dhawan V, Przedborski S, Jackson-Lewis V, Mentis MJ, et al. (2001) Metabolic correlates of levodopa response in Parkinson\u2019s disease. Neurology 57:2083\u20132088","journal-title":"Neurology"},{"key":"85_CR9","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/ana.10418","volume":"52","author":"M Trost","year":"2002","unstructured":"Trost M, Carbon M, Edwards C, Ma Y, Raymond D, Mentis MJ, et al. (2002) Primary dystonia: is abnormal functional brain architecture linked to genotype? Ann Neurol 52:853\u2013856","journal-title":"Ann Neurol"},{"key":"85_CR10","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neuroimage.2004.04.032","volume":"23","author":"N Scarmeas","year":"2004","unstructured":"Scarmeas N, Habeck CG, Zarahn E, Anderson KE, Park A, Hilton J, et al. (2004) Covariance PET patterns in early Alzheimer\u2019s disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance. NeuroImage 23:35\u201345","journal-title":"NeuroImage"},{"key":"85_CR11","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1602\/neurorx.2.2.361","volume":"2","author":"T Eckert","year":"2005","unstructured":"Eckert T, Eidelberg D (2005) Neuroimaging and therapeutics in movement disorders. NeuroRx 2:361\u2013371","journal-title":"NeuroRx"},{"key":"85_CR12","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1212\/01.WNL.0000147469.18313.3B","volume":"63","author":"L Mosconi","year":"2004","unstructured":"Mosconi L, Perani D, Sorbi S, Herholz K, Nacmias B, Holthoff V, et al. (2004) MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET. Neurology 63:2332\u20132340","journal-title":"Neurology"},{"key":"85_CR13","doi-asserted-by":"crossref","unstructured":"Huang C, Eidelberg D, Habeck C, Moeller J, Svensson L, Tarabula T, et al. (2006) Imaging markers of mild cognitive impairment: multivariate analysis of CBF SPECT. Neurobiol Aging (in press). DOI 10.1016\/j.neurobiolaging.2006.05.017","DOI":"10.1016\/j.neurobiolaging.2006.05.017"},{"key":"85_CR14","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.neuroimage.2005.10.016","volume":"30","author":"E Salmon","year":"2006","unstructured":"Salmon E, Kerrouche N, Herholz K, Perani D, Holthoff V, Beuthien-Baumann B, et al. (2006) Decomposition of metabolic brain clusters in the frontal variant of frontotemporal dementia. NeuroImage 30:871\u2013878","journal-title":"NeuroImage"},{"key":"85_CR15","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1038\/sj.jcbfm.9600296","volume":"26","author":"N Kerrouche","year":"2006","unstructured":"Kerrouche N, Herholz K, Mielke R, Holthoff V, Baron JC (2006) 18FDG-PET in vascular dementia: differentiation from Alzheimer\u2019s disease using voxel-based multivariate analysis. J Cereb Blood Flow Metab 26:1213\u20131221","journal-title":"J Cereb Blood Flow Metab"},{"key":"85_CR16","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.1093\/brain\/awh166","volume":"127","author":"F Eustache","year":"2004","unstructured":"Eustache F, Piolino P, Giffard B, Viader F, De La Sayette V, Baron JC, et al. (2004) \u2018In the course of time\u2019: a PET study of the cerebral substrates of autobiographical amnesia in Alzheimer\u2019s disease. Brain 127:1549\u20131560","journal-title":"Brain"},{"key":"85_CR17","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1212\/01.WNL.0000120541.97467.FE","volume":"62","author":"M Carbon","year":"2004","unstructured":"Carbon M, Su S, Dhawan V, Raymond D, Bressman S, Eidelberg D (2004) Regional metabolism in primary torsion dystonia: effects of penetrance and genotype. Neurology 62:1384\u20131390","journal-title":"Neurology"},{"key":"85_CR18","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1002\/ana.20442","volume":"57","author":"K Asanuma","year":"2005","unstructured":"Asanuma K, Ma Y, Huang C, Carbon M, Edwards C, Raymond D, et al. (2005) The metabolic pathology of dopa-responsive dystonia. Ann Neurol 57:596\u2013600","journal-title":"Ann Neurol"},{"key":"85_CR19","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/ana.10610","volume":"54","author":"MF Ghilardi","year":"2003","unstructured":"Ghilardi MF, Carbon M, Silvestri G, Dhawan V, Tagliati M, Bressman S, et al. (2003) Impaired sequence learning in carriers of the DYT1 dystonia mutation. Ann Neurol 54:102\u2013109","journal-title":"Ann Neurol"},{"key":"85_CR20","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1093\/brain\/awh213","volume":"127","author":"O Detante","year":"2004","unstructured":"Detante O, Vercueil L, Thobois S, Broussolle E, Costes N, Lavenne F, et al. (2004) Globus pallidus internus stimulation in primary generalized dystonia: a H215O PET study. Brain 127:1899\u20131908","journal-title":"Brain"},{"key":"85_CR21","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jocn.2004.05.010","volume":"12","author":"J Yianni","year":"2005","unstructured":"Yianni J, Bradley K, Soper N, O\u2019Sullivan V, Nandi D, Gregory R, et al. (2005) Effect of GPi DBS on functional imaging of the brain in dystonia. J Clin Neurosci 12:137\u2013141","journal-title":"J Clin Neurosci"},{"key":"85_CR22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-1-59259-888-5_5","volume-title":"Bioimaging in neurodegeneration","author":"Y Ma","year":"2005","unstructured":"Ma Y, Dhawan V, Freed C, Fahn S, Eidelberg D (2005) PET and embryonic dopamine cell transplantation in Parkinson\u2019s disease. In: Broderick PA, Rabni DN, Kolodny EH (eds) Bioimaging in neurodegeneration. New Jersey: Humana Press, pp 45\u201358"},{"key":"85_CR23","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/S1053-8119(03)00348-3","volume":"20","author":"AL Brownell","year":"2003","unstructured":"Brownell AL, Canales K, Chen YI, Jenkins BG, Owen C, Livni E, et al. (2003) Mapping of brain function after MPTP-induced neurotoxicity in a primate Parkinson\u2019s disease model. NeuroImage 20:1064\u20131075","journal-title":"NeuroImage"},{"key":"85_CR24","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1136\/jnnp.54.10.898","volume":"54","author":"M Otsuka","year":"1991","unstructured":"Otsuka M, Ichiya Y, Hosokawa S, Kuwabara Y, Tahara T, Fukumura T, et al. (1991) Striatal blood flow, glucose metabolism and 18F-dopa uptake: difference in Parkinson\u2019s disease and atypical parkinsonism. J Neurol Neurosurg Psychiatry 54:898\u2013904","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"85_CR25","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s004150050364","volume":"246","author":"K Okada","year":"1999","unstructured":"Okada K, Suyama N, Oguro H, Yamaguchi S, Kobayashi S (1999) Medication-induced hallucination and cerebral blood flow in Parkinson\u2019s disease. J Neurol 246:365\u2013368","journal-title":"J Neurol"},{"key":"85_CR26","doi-asserted-by":"crossref","unstructured":"Emborg ME, Carbon M, Holden JE, During MJ, Ma Y, Tang C, et al. (2006) Subthalamic glutamic acid decarboxylase gene therapy: changes in motor function and cortical metabolism. J Cereb Blood Flow Metab (in press). DOI 10.1038\/sj.jcbfm.9600364","DOI":"10.1038\/sj.jcbfm.9600364"},{"key":"85_CR27","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S0022-510X(96)00172-4","volume":"144","author":"M Otsuka","year":"1996","unstructured":"Otsuka M, Ichiya Y, Kuwabara Y, Hosokawa S, Sasaki M, Yoshida T, et al. (1996) Glucose metabolism in the cortical and subcortical brain structures in multiple system atrophy and Parkinson\u2019s disease: a positron emission tomographic study. J Neurol Sci 144:77\u201383","journal-title":"J Neurol Sci"},{"key":"85_CR28","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1002\/mds.870130212","volume":"13","author":"A Antonini","year":"1998","unstructured":"Antonini A, Kazumata K, Feigin A, Mandel F, Dhawan V, Margouleff C, et al. (1998) Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET. Mov Disord 13:268\u2013274","journal-title":"Mov Disord"},{"key":"85_CR29","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1002\/mds.20493","volume":"20","author":"RC Klein","year":"2005","unstructured":"Klein RC, de Jong BM, de Vries JJ, Leenders KL (2005) Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson\u2019s disease. Mov Disord 20:1021\u20131030","journal-title":"Mov Disord"},{"key":"85_CR30","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.neuroimage.2005.03.012","volume":"26","author":"T Eckert","year":"2005","unstructured":"Eckert T, Barnes A, Dhawan V, Frucht S, Gordon MF, Feigin AS, et al. (2005) FDG-PET in the differential diagnosis of parkinsonian disorders. NeuroImage 26:912\u2013921","journal-title":"NeuroImage"},{"key":"85_CR31","first-page":"1264","volume":"40","author":"JR Moeller","year":"1999","unstructured":"Moeller JR, Nakamura T, Mentis MJ, Dhawan V, Spetsieres P, Antonini A, et al. (1999) Reproducibility of regional metabolic covariance patterns: comparison of four populations. J Nucl Med 40:1264\u20131269","journal-title":"J Nucl Med"},{"key":"85_CR32","doi-asserted-by":"publisher","first-page":"872","DOI":"10.3171\/jns.2003.99.5.0872","volume":"99","author":"M Trost","year":"2003","unstructured":"Trost M, Su PC, Barnes A, Su SL, Yen RF, Tseng HM, et al. (2003) Evolving metabolic changes during the first postoperative year after subthalamotomy. J Neurosurg 99:872\u2013878","journal-title":"J Neurosurg"},{"key":"85_CR33","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/hbm.20033","volume":"22","author":"C Lozza","year":"2004","unstructured":"Lozza C, Baron JC, Eidelberg D, Mentis MJ, Carbon M, Marie RM (2004) Executive processes in Parkinson\u2019s disease: FDG-PET and network analysis. Hum Brain Mapp 22:236\u2013245","journal-title":"Hum Brain Mapp"},{"key":"85_CR34","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s00415-005-0993-7","volume":"253","author":"V Kaasinen","year":"2006","unstructured":"Kaasinen V, Maguire RP, Hundemer HP, Leenders KL (2006) Corticostriatal covariance patterns of 6-[18F]fluoro-l-dopa and [18F]fluorodeoxyglucose PET in Parkinson\u2019s disease. J Neurol 253:340\u2013348","journal-title":"J Neurol"},{"key":"85_CR35","first-page":"378","volume":"36","author":"D Eidelberg","year":"1995","unstructured":"Eidelberg D, Moeller JR, Ishikawa T, Dhawan V, Spetsieris P, Chaly T, et al. (1995) Assessment of disease severity in parkinsonism with fluorine-18-fluorodeoxyglucose and PET. J Nucl Med 36:378\u2013383","journal-title":"J Nucl Med"},{"key":"85_CR36","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1093\/brain\/120.8.1315","volume":"120","author":"D Eidelberg","year":"1997","unstructured":"Eidelberg D, Moeller JR, Kazumata K, Antonini A, Sterio D, Dhawan V, et al. (1997) Metabolic correlates of pallidal neuronal activity in Parkinson\u2019s disease. Brain 120:1315\u20131324","journal-title":"Brain"},{"key":"85_CR37","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1093\/brain\/awl162","volume":"129","author":"K Asanuma","year":"2006","unstructured":"Asanuma K, Tang C, Ma Y, Dhawan V, Mattis P, Edwards C, et al. (2006) Network modulation in the treatment of Parkinson\u2019s disease. Brain 129:2667\u20132678","journal-title":"Brain"},{"key":"85_CR38","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.neuroimage.2006.09.003","volume":"34","author":"C Huang","year":"2006","unstructured":"Huang C, Mattis P, Tang C, Perrine K, Carbon M, Eidelberg D (2006) Metabolic brain networks associated with cognitive function in Parkinson\u2019s disease. NeuroImage 34:714\u2013723","journal-title":"NeuroImage"},{"key":"85_CR39","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1176\/appi.ajp.159.5.746","volume":"159","author":"MJ Mentis","year":"2002","unstructured":"Mentis MJ, McIntosh AR, Perrine K, Dhawan V, Berlin B, Feigin A, et al. (2002) Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson\u2019s disease. Am J Psychiatry 159:746\u2013754","journal-title":"Am J Psychiatry"},{"issue":"5M","key":"85_CR40","first-page":"1","volume":"6144","author":"P Spetsieris","year":"2006","unstructured":"Spetsieris P, Ma Y, Dhawan V, Moeller JR, Eidelberg D. (2006) Highly automated computer-aided diagnosis of neurological disorders using functional brain imaging. Proc SPIE Int Soc Opt Eng-Medical Imaging 6144(5M):1\u201312","journal-title":"Proc SPIE Int Soc Opt Eng-Medical Imaging"},{"key":"85_CR41","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1002\/mds.10270","volume":"17","author":"A Feigin","year":"2002","unstructured":"Feigin A, Antonini A, Fukuda M, De Notaris R, Benti R, Pezzoli G, et al. (2002) Tc-99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism. Mov Disord 17:1265\u20131270","journal-title":"Mov Disord"},{"key":"85_CR42","doi-asserted-by":"crossref","unstructured":"Eckert T, Van Laere KV, Tang C, Lewis DE, Santens P, Eidelberg D (2006) Quantification of PD-related network expression with ECD SPECT. Eur J Nucl Med Mol Imaging (in press). DOI 10.1007\/s00259-006-0261-9","DOI":"10.1007\/s00259-006-0261-9"},{"key":"85_CR43","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1097\/00004647-200209000-00013","volume":"22","author":"TJ Carroll","year":"2002","unstructured":"Carroll TJ, Teneggi V, Jobin M, Squassante L, Treyer V, Hany TF, et al. (2002) Absolute quantification of cerebral blood flow with magnetic resonance, reproducibility of the method, and comparison with H2(15)O positron emission tomography. J Cereb Blood Flow Metab 22:1149\u20131156","journal-title":"J Cereb Blood Flow Metab"},{"key":"85_CR44","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/mrm.10140","volume":"47","author":"YF Yen","year":"2002","unstructured":"Yen YF, Field AS, Martin EM, Ari N, Burdette JH, Moody DM, et al. (2002) Test\u2013retest reproducibility of quantitative CBF measurements using FAIR perfusion MRI and acetazolamide challenge. Magn Reson Med 47:921\u2013928","journal-title":"Magn Reson Med"},{"key":"85_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jmri.10133","volume":"16","author":"A Spilt","year":"2002","unstructured":"Spilt A, Box FM, van der Geest RJ, Reiber JH, Kunz P, Kamper AM, et al. (2002) Reproducibility of total cerebral blood flow measurements using phase contrast magnetic resonance imaging. J Magn Reson Imaging 16:1\u20135","journal-title":"J Magn Reson Imaging"},{"key":"85_CR46","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/jmri.10416","volume":"18","author":"TF Floyd","year":"2003","unstructured":"Floyd TF, Ratcliffe SJ, Wang J, Resch B, Detre JA (2003) Precision of the CASL-perfusion MRI technique for the measurement of cerebral blood flow in whole brain and vascular territories. J Magn Reson Imaging 18:649\u2013655","journal-title":"J Magn Reson Imaging"},{"key":"85_CR47","first-page":"A235","volume":"64","author":"C Huang","year":"2005","unstructured":"Huang C, Feigin A, Ma Y, Eidelberg D (2005) Imaging measures of longitudinal change in Parkinson\u2019s disease. Neurology 64:A235","journal-title":"Neurology"},{"key":"85_CR48","first-page":"725","volume":"43","author":"S Sestini","year":"2002","unstructured":"Sestini S, Scotto di Luzio A, Ammannati F, De Cristofaro MT, Passeri A, Martini S, et al. (2002) Changes in regional cerebral blood flow caused by deep-brain stimulation of the subthalamic nucleus in Parkinson\u2019s disease. J Nucl Med 43:725\u2013732","journal-title":"J Nucl Med"},{"key":"85_CR49","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1001\/archneur.56.8.997","volume":"56","author":"AO Ceballos-Baumann","year":"1999","unstructured":"Ceballos-Baumann AO, Boecker H, Bartenstein P, von Falkenhayn I, Riescher H, Conrad B, et al. (1999) A positron emission tomographic study of subthalamic nucleus stimulation in Parkinson disease: enhanced movement-related activity of motor-association cortex and decreased motor cortex resting activity. Arch Neurol 56:997\u20131003","journal-title":"Arch Neurol"},{"key":"85_CR50","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/ana.10683","volume":"54","author":"U Schroeder","year":"2003","unstructured":"Schroeder U, Kuehler A, Lange KW, Haslinger B, Tronnier VM, Krause M, et al. (2003) Subthalamic nucleus stimulation affects a frontotemporal network: a PET study. Ann Neurol 54:445\u2013450","journal-title":"Ann Neurol"},{"key":"85_CR51","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jns.2006.05.005","volume":"248","author":"M Carbon","year":"2006","unstructured":"Carbon M, Eidelberg D (2006) Functional imaging of sequence learning in Parkinson\u2019s disease. J Neurol Sci 248:72\u201377","journal-title":"J Neurol Sci"},{"key":"85_CR52","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/ana.1232","volume":"50","author":"PC Su","year":"2001","unstructured":"Su PC, Ma Y, Fukuda M, Mentis MJ, Tseng HM, Yen RF, et al. (2001) Metabolic changes following subthalamotomy for advanced Parkinson\u2019s disease. Ann Neurol 50:514\u2013520","journal-title":"Ann Neurol"},{"key":"85_CR53","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1093\/brain\/124.8.1601","volume":"124","author":"M Fukuda","year":"2001","unstructured":"Fukuda M, Mentis MJ, Ma Y, Dhawan V, Antonini A, Lang AE, et al. (2001) Networks mediating the clinical effects of pallidal brain stimulation for Parkinson\u2019s disease: a PET study of resting-state glucose metabolism. Brain 124:1601\u20131609","journal-title":"Brain"},{"key":"85_CR54","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.neuroimage.2005.12.024","volume":"31","author":"M Trost","year":"2006","unstructured":"Trost M, Su S, Su P, Yen RF, Tseng HM, Barnes A, et al. (2006) Network modulation by the subthalamic nucleus in the treatment of Parkinson\u2019s disease. NeuroImage 31:301\u2013307","journal-title":"NeuroImage"},{"key":"85_CR55","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/01.WCB.0000092831.44769.09","volume":"24","author":"R Hilker","year":"2004","unstructured":"Hilker R, Voges J, Weisenbach S, Kalbe E, Burghaus L, Ghaemi M, et al. (2004) Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson\u2019s disease. J Cereb Blood Flow Metab 24:7\u201316","journal-title":"J Cereb Blood Flow Metab"},{"key":"85_CR56","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0188-0128(98)00007-4","volume":"30","author":"R Drucker-Colin","year":"1999","unstructured":"Drucker-Colin R, Verdugo-Diaz L, Morgado-Valle C, Solis-Maldonado G, Ondarza R, Boll C, et al. (1999) Transplant of cultured neuron-like differentiated chromaffin cells in a Parkinson\u2019s disease patient. A preliminary report. Arch Med Res 30:33\u201339","journal-title":"Arch Med Res"},{"key":"85_CR57","unstructured":"Feigin A, Tang C, Ma Y, Dhawan V, During MJ, Kaplitt MG, et al. (2006) Gene therapy for Parkinson\u2019s disease with AAV-GAD: interim FDG-PET results. Neurology 66 (5, Suppl 2)"},{"key":"85_CR58","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/1531-8257(200005)15:3<552::AID-MDS1020>3.0.CO;2-P","volume":"15","author":"EH Aylward","year":"2000","unstructured":"Aylward EH, Codori AM, Rosenblatt A, Sherr M, Brandt J, Stine OC, et al. (2000) Rate of caudate atrophy in presymptomatic and symptomatic stages of Huntington\u2019s disease. Mov Disord 15:552\u2013560","journal-title":"Mov Disord"},{"key":"85_CR59","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1212\/WNL.57.6.1025","volume":"57","author":"HD Rosas","year":"2001","unstructured":"Rosas HD, Goodman J, Chen YI, Jenkins BG, Kennedy DN, Makris N, et al. (2001) Striatal volume loss in HD as measured by MRI and the influence of CAG repeat. Neurology 57:1025\u20131028","journal-title":"Neurology"},{"key":"85_CR60","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1093\/brain\/awf179","volume":"125","author":"MJ Thieben","year":"2002","unstructured":"Thieben MJ, Duggins AJ, Good CD, Gomes L, Mahant N, Richards F, et al. (2002) The distribution of structural neuropathology in pre-clinical Huntington\u2019s disease. Brain 125:1815\u20131818","journal-title":"Brain"},{"key":"85_CR61","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1093\/brain\/119.6.2085","volume":"119","author":"A Antonini","year":"1996","unstructured":"Antonini A, Leenders KL, Spiegel R, Meier D, Vontobel P, Weigell-Weber M, et al. (1996) Striatal glucose metabolism and dopamine D2 receptor binding in asymptomatic gene carriers and patients with Huntington\u2019s disease. Brain 119:2085\u20132095","journal-title":"Brain"},{"key":"85_CR62","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/ana.410400110","volume":"40","author":"RA Weeks","year":"1996","unstructured":"Weeks RA, Piccini P, Harding AE, Brooks DJ (1996) Striatal D1 and D2 dopamine receptor loss in asymptomatic mutation carriers of Huntington\u2019s disease. Ann Neurol 40:49\u201354","journal-title":"Ann Neurol"},{"key":"85_CR63","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1212\/01.wnl.0000176071.08694.cc","volume":"65","author":"JC van Oostrom","year":"2005","unstructured":"van Oostrom JC, Maguire RP, Verschuuren-Bemelmans CC, Veenma-van der Duin L, Pruim J, Roos RA, et al. (2005) Striatal dopamine D2 receptors, metabolism, and volume in preclinical Huntington disease. Neurology 65:941\u2013943","journal-title":"Neurology"},{"key":"85_CR64","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1093\/brain\/120.12.2207","volume":"120","author":"L Backman","year":"1997","unstructured":"Backman L, Robins-Wahlin TB, Lundin A, Ginovart N, Farde L (1997) Cognitive deficits in Huntington\u2019s disease are predicted by dopaminergic PET markers and brain volumes. Brain 120:2207\u20132217","journal-title":"Brain"},{"key":"85_CR65","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/ana.410430216","volume":"43","author":"A Antonini","year":"1998","unstructured":"Antonini A, Leenders KL, Eidelberg D (1998) [11C]raclopride-PET studies of the Huntington\u2019s disease rate of progression: relevance of the trinucleotide repeat length. Ann Neurol 43:253\u2013255","journal-title":"Ann Neurol"},{"key":"85_CR66","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1093\/brain\/122.12.2353","volume":"122","author":"TC Andrews","year":"1999","unstructured":"Andrews TC, Weeks RA, Turjanski N, Gunn RN, Watkins LH, Sahakian B, et al. (1999) Huntington\u2019s disease progression. PET and clinical observations. Brain 122:2353\u20132363","journal-title":"Brain"},{"key":"85_CR67","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1093\/brain\/awg119","volume":"126","author":"N Pavese","year":"2003","unstructured":"Pavese N, Andrews TC, Brooks DJ, Ho AK, Rosser AE, Barker RA, et al. (2003) Progressive striatal and cortical dopamine receptor dysfunction in Huntington\u2019s disease: a PET study. Brain 126:1127\u20131135","journal-title":"Brain"},{"key":"85_CR68","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1006\/exnr.2000.7514","volume":"166","author":"DM Araujo","year":"2000","unstructured":"Araujo DM, Cherry SR, Tatsukawa KJ, Toyokuni T, Kornblum HI (2000) Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington\u2019s disease. Exp Neurol 166:287\u2013297","journal-title":"Exp Neurol"},{"key":"85_CR69","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/mds.870080118","volume":"8","author":"T Kuwert","year":"1993","unstructured":"Kuwert T, Noth J, Scholz D, Schwarz M, Lange HW, Topper R, et al. (1993) Comparison of somatosensory evoked potentials with striatal glucose consumption measured by positron emission tomography in the early diagnosis of Huntington\u2019s disease. Mov Disord 8:98\u2013106","journal-title":"Mov Disord"},{"key":"85_CR70","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1212\/WNL.36.7.888","volume":"36","author":"MR Hayden","year":"1986","unstructured":"Hayden MR, Martin WR, Stoessl AJ, Clark C, Hollenberg S, Adam MJ, et al. (1986) Positron emission tomography in the early diagnosis of Huntington\u2019s disease. Neurology 36:888\u2013894","journal-title":"Neurology"},{"key":"85_CR71","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/ana.410200305","volume":"20","author":"AB Young","year":"1986","unstructured":"Young AB, Penney JB, Starosta-Rubinstein S, Markel DS, Berent S, Giordani B, et al. (1986) PET scan investigations of Huntington\u2019s disease: cerebral metabolic correlates of neurological features and functional decline. Ann Neurol 20:296\u2013303","journal-title":"Ann Neurol"},{"key":"85_CR72","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1002\/ana.410230603","volume":"23","author":"S Berent","year":"1988","unstructured":"Berent S, Giordani B, Lehtinen S, Markel D, Penney JB, Buchtel HA, et al. (1988) Positron emission tomographic scan investigations of Huntington\u2019s disease: cerebral metabolic correlates of cognitive function. Ann Neurol 23:541\u2013546","journal-title":"Ann Neurol"},{"key":"85_CR73","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1093\/brain\/113.5.1405","volume":"113","author":"T Kuwert","year":"1990","unstructured":"Kuwert T, Lange HW, Langen KJ, Herzog H, Aulich A, Feinendegen LE (1990) Cortical and subcortical glucose consumption measured by PET in patients with Huntington\u2019s disease. Brain 113:1405\u20131423","journal-title":"Brain"},{"key":"85_CR74","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/archneur.1992.00530350075022","volume":"49","author":"ST Grafton","year":"1992","unstructured":"Grafton ST, Mazziotta JC, Pahl JJ, St George-Hyslop P, Haines JL, Gusella J, et al. (1992) Serial changes of cerebral glucose metabolism and caudate size in persons at risk for Huntington\u2019s disease. Arch Neurol 49:1161\u20131167","journal-title":"Arch Neurol"},{"key":"85_CR75","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1212\/WNL.42.1.223","volume":"42","author":"WR Martin","year":"1992","unstructured":"Martin WR, Clark C, Ammann W, Stoessl AJ, Shtybel W, Hayden MR (1992) Cortical glucose metabolism in Huntington\u2019s disease. Neurology 42:223\u2013229","journal-title":"Neurology"},{"key":"85_CR76","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1002\/mds.870110612","volume":"11","author":"DS Sax","year":"1996","unstructured":"Sax DS, Powsner R, Kim A, Tilak S, Bhatia R, Cupples LA, et al. (1996) Evidence of cortical metabolic dysfunction in early Huntington\u2019s disease by single-photon-emission computed tomography. Mov Disord 11:671\u2013677","journal-title":"Mov Disord"},{"key":"85_CR77","first-page":"215","volume":"47","author":"A Ciarmiello","year":"2006","unstructured":"Ciarmiello A, Cannella M, Lastoria S, Simonelli M, Frati L, Rubinsztein DC, et al. (2006) Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington\u2019s disease. J Nucl Med 47:215\u2013222","journal-title":"J Nucl Med"},{"key":"85_CR78","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1399-0004.2004.00241.x","volume":"65","author":"DR Langbehn","year":"2004","unstructured":"Langbehn DR, Brinkman RR, Falush D, Paulsen JS, Hayden MR (2004) A new model for prediction of the age of onset and penetrance for Huntington\u2019s disease based on CAG length. Clin Genet 65:267\u2013277","journal-title":"Clin Genet"},{"key":"85_CR79","first-page":"209p","volume":"47","author":"Y Ma","year":"2006","unstructured":"Ma Y, Feigin A, Rachakonda S, Dhawan V, Eidelberg D. (2006) Evolution of metabolic brain networks in presymptomatic Huntington\u2019s disease: a longitudinal PET study. J Nucl Med 47:209p","journal-title":"J Nucl Med"},{"key":"85_CR80","first-page":"1591","volume":"42","author":"A Feigin","year":"2001","unstructured":"Feigin A, Leenders KL, Moeller JR, Missimer J, Kuenig G, Spetsieris P, et al. (2001) Metabolic network abnormalities in early Huntington\u2019s disease: an [(18)F]FDG-PET study. J Nucl Med 42:1591\u20131595","journal-title":"J Nucl Med"},{"key":"85_CR81","unstructured":"Ma Y, Feigin A, Okulski J, Dhawan V, Chaly T, Eidelberg D (2003) Implementation of atrophy correction in metabolic mapping studies of presymptomatic Huntington\u2019s disease. J Cereb Blood Flow Metab S629"},{"key":"85_CR82","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/ana.20684","volume":"59","author":"A Feigin","year":"2006","unstructured":"Feigin A, Ghilardi MF, Huang C, Ma Y, Carbon M, Guttman M, et al. (2006) Preclinical Huntington\u2019s disease: compensatory brain responses during learning. Ann Neurol 59:53\u201359","journal-title":"Ann Neurol"},{"key":"85_CR83","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/00019052-200308000-00010","volume":"16","author":"SM Hersch","year":"2003","unstructured":"Hersch SM (2003) Huntington\u2019s disease: prospects for neuroprotective therapy 10\u00a0years after the discovery of the causative genetic mutation. Curr Opin Neurol 16:501\u2013506","journal-title":"Curr Opin Neurol"},{"key":"85_CR84","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jns.2004.12.011","volume":"231","author":"X Wang","year":"2005","unstructured":"Wang X, Sarkar A, Cicchetti F, Yu M, Zhu A, Jokivarsi K, et al. (2005) Cerebral PET imaging and histological evidence of transglutaminase inhibitor cystamine induced neuroprotection in transgenic R6\/2 mouse model of Huntington\u2019s disease. J Neurol Sci 231:57\u201366","journal-title":"J Neurol Sci"},{"key":"85_CR85","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1177\/096368979200100409","volume":"1","author":"JM Schumacher","year":"1992","unstructured":"Schumacher JM, Hantraye P, Brownell AL, Riche D, Madras BK, Davenport PD, et al. (1992) A primate model of Huntington\u2019s disease: functional neural transplantation and CT-guided stereotactic procedures. Cell Transplant 1:313\u2013322","journal-title":"Cell Transplant"},{"key":"85_CR86","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1093\/brain\/awh003","volume":"127","author":"V Gaura","year":"2004","unstructured":"Gaura V, Bachoud-Levi AC, Ribeiro MJ, Nguyen JP, Frouin V, Baudic S, et al. (2004) Striatal neural grafting improves cortical metabolism in Huntington\u2019s disease patients. Brain 127:65\u201372","journal-title":"Brain"},{"key":"85_CR87","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/ana.20564","volume":"58","author":"S Furtado","year":"2005","unstructured":"Furtado S, Sossi V, Hauser RA, Samii A, Schulzer M, Murphy CB, et al. (2005) Positron emission tomography after fetal transplantation in Huntington\u2019s disease. Ann Neurol 58:331\u2013337","journal-title":"Ann Neurol"},{"key":"85_CR88","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1002\/ana.20183","volume":"56","author":"E Moro","year":"2004","unstructured":"Moro E, Lang AE, Strafella AP, Poon YY, Arango PM, Dagher A, et al. (2004) Bilateral globus pallidus stimulation for Huntington\u2019s disease. Ann Neurol 56:290\u2013294","journal-title":"Ann Neurol"}],"container-title":["Molecular Imaging and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-007-0085-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11307-007-0085-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-007-0085-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11307-007-0085-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,15]],"date-time":"2022-05-15T03:17:49Z","timestamp":1652584669000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11307-007-0085-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,3]]},"references-count":88,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,7]]}},"alternative-id":["85"],"URL":"https:\/\/doi.org\/10.1007\/s11307-007-0085-4","relation":{},"ISSN":["1536-1632","1860-2002"],"issn-type":[{"value":"1536-1632","type":"print"},{"value":"1860-2002","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,3]]},"assertion":[{"value":"3 March 2007","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}